« Back
Home /
regorafenib-d3

regorafenib-d3

Item no.	V40445-25mg
Manufacturer	InvivoChem LLC
CASRN	1255386-16-3
Amount	25 mg
Quantity options	100 mg 10 mg 1 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V40445CAS #:1255386-16-3Purity >=98% Regorafenib D3 (BAY 73-4506 D3) is a deuterated form of Regorafenib. Regorafenib(also known as BAY 73-4506) is a multi-kinase inhibitor which targetsVEGFR1, VEGFR2, VEGFR3, PDGFRbeta, Kit, RET and Raf-1 with IC50 values of13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively. It is an orally bioavailable small molecule that hasanticancer activity and has been approved by FDA for the treatment ofliver cancer. Int J Cancer, 2011, 129(1), 245-255.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Delivery expected until 7/3/2025

Express Delivery: Save 16 days

Compare

Add to wishlist

Recommend by mail